283 related articles for article (PubMed ID: 21992114)
1. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
Sevrioukova IF; Poulos TL
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
[TBL] [Abstract][Full Text] [Related]
3. Homotropic Cooperativity of Midazolam Metabolism by Cytochrome P450 3A4: Insight from Computational Studies.
Li J; Chen Y; Tang Y; Li W; Tu Y
J Chem Inf Model; 2021 May; 61(5):2418-2426. PubMed ID: 33884878
[TBL] [Abstract][Full Text] [Related]
4. Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4.
Rougée LRA; Bedwell DW; Hansen K; Abraham TL; Hall SD
Drug Metab Dispos; 2023 Oct; 51(10):1372-1380. PubMed ID: 37524542
[TBL] [Abstract][Full Text] [Related]
5. Midazolam as a Probe for Drug-Drug Interactions Mediated by CYP3A4: Homotropic Allosteric Mechanism of Site-Specific Hydroxylation.
Denisov IG; Grinkova YV; Camp T; McLean MA; Sligar SG
Biochemistry; 2021 Jun; 60(21):1670-1681. PubMed ID: 34015213
[TBL] [Abstract][Full Text] [Related]
6. Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study.
Cameron MD; Wen B; Allen KE; Roberts AG; Schuman JT; Campbell AP; Kunze KL; Nelson SD
Biochemistry; 2005 Nov; 44(43):14143-51. PubMed ID: 16245930
[TBL] [Abstract][Full Text] [Related]
7. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
[TBL] [Abstract][Full Text] [Related]
8. Molecular Insights into the Heterotropic Allosteric Mechanism in Cytochrome P450 3A4-Mediated Midazolam Metabolism.
Fu T; Zhang H; Zheng Q
J Chem Inf Model; 2022 Nov; 62(22):5762-5770. PubMed ID: 36342224
[TBL] [Abstract][Full Text] [Related]
9. Dynamics and Location of the Allosteric Midazolam Site in Cytochrome P4503A4 in Lipid Nanodiscs.
Redhair M; Hackett JC; Pelletier RD; Atkins WM
Biochemistry; 2020 Feb; 59(6):766-779. PubMed ID: 31961139
[TBL] [Abstract][Full Text] [Related]
10. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
11. Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.
Denisov IG; Grinkova YV; McLean MA; Camp T; Sligar SG
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740978
[TBL] [Abstract][Full Text] [Related]
12. Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions.
Blobaum AL; Bridges TM; Byers FW; Turlington ML; Mattmann ME; Morrison RD; Mackie C; Lavreysen H; Bartolomé JM; Macdonald GJ; Steckler T; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Stauffer SR; Daniels JS
Drug Metab Dispos; 2013 Dec; 41(12):2066-75. PubMed ID: 24003250
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of Shenmai injection, a herbal preparation, on the cytochrome P450 3A-mediated 1'-hydroxylation and 4-hydroxylation of midazolam.
Xia C; Sun J; Wang G; Shang L; Zhang X; Zhang R; Wang X; Hao H; Xie L
Chem Biol Interact; 2009 Aug; 180(3):440-8. PubMed ID: 19557931
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.
Quintieri L; Palatini P; Nassi A; Ruzza P; Floreani M
Biochem Pharmacol; 2008 Mar; 75(6):1426-37. PubMed ID: 18191104
[TBL] [Abstract][Full Text] [Related]
15. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
Tang W; Stearns RA
Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
[TBL] [Abstract][Full Text] [Related]
16. Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation.
Khan KK; He YQ; Domanski TL; Halpert JR
Mol Pharmacol; 2002 Mar; 61(3):495-506. PubMed ID: 11854429
[TBL] [Abstract][Full Text] [Related]
17. Evidence of CYP3A allosterism in vivo: analysis of interaction between fluconazole and midazolam.
Yang J; Atkins WM; Isoherranen N; Paine MF; Thummel KE
Clin Pharmacol Ther; 2012 Mar; 91(3):442-9. PubMed ID: 22048224
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the molecular and mechanistic basis for the regioselective metabolism of midazolam by cytochrome P450 3A4.
Fu T; Zheng Q; Zhang H
Phys Chem Chem Phys; 2022 Apr; 24(14):8104-8112. PubMed ID: 35319551
[TBL] [Abstract][Full Text] [Related]
19. Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone.
Miyazaki M; Nakamura K; Fujita Y; Guengerich FP; Horiuchi R; Yamamoto K
Drug Metab Dispos; 2008 Nov; 36(11):2287-91. PubMed ID: 18669585
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
